VAERS reports by lot

Pfizer COVID-19 lot 330368D: VAERS reports

301 VAERS reports list lot 330368D as a Pfizer COVID-19 vaccine, received between 2021-12-23 and 2024-08-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
301
Reports
10%
Marked serious
2
With a death outcome
22
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)10019%
Neurological9919%
Gastrointestinal6813%
Musculoskeletal5010%
Injection-site / Local reaction489%
Cardiac / Cardiovascular459%
Respiratory306%
Dermatological (non-injection-site)296%
Allergic / Anaphylactic285%
Autoimmune / Immune-mediated82%
Psychiatric / Neuropsychiatric71%
Reproductive / Menstrual51%
Thrombotic / Hematological31%

Where reports came from

U.S. state of the reporter, where given (top 12).

Puerto Rico57
Minnesota54
California22
Michigan20
Colorado14
New York11
Texas9
Wisconsin8
Maryland5
Hawaii4
Washington4
Massachusetts4

Reports by month received

2021-126
2022-01181
2022-0224
2022-0311
2022-044
2022-055
2022-068
2022-074
2022-082
2022-0936
2022-101
2022-112
2022-122
2023-011
2023-021
2023-034
2023-041
2023-064
2023-071
2023-081
2023-121
2024-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.